Semaglutide vs. Warfarin
Compare Semaglutide and Warfarin: mechanism of action, indications, side effects, cost, and which may be right for you.
Quick Comparison
| Category | Semaglutide | Warfarin |
|---|---|---|
| Drug Class | GLP-1 Receptor Agonists | Anticoagulants |
| Rx Status | Rx | Rx |
| Generic Available | No | No |
| Typical Cost | $935–$1,349/month | $10–$30/month |
Semaglutide Overview
Semaglutide is a once-weekly (or once-daily oral) GLP-1 receptor agonist that lowers blood sugar and reduces body weight by mimicking the natural gut hormone GLP-1. It is sold under three brand names — Ozempic (injectable, type 2 diabetes), Wegovy (injectable, weight management), and Rybelsus (oral tablet, type 2 diabetes) — all manufactured by Novo Nordisk. Clinical trials show it reduces HbA1c b...
Full Semaglutide guide →Warfarin Overview
Warfarin is a "blood thinner" (anticoagulant) medication that helps prevent harmful blood clots from forming or growing larger in your body. It is prescribed to reduce the risk of serious problems like strokes, heart attacks, and clots in the legs or lungs, especially for people with certain heart conditions or after a heart attack.
Full Warfarin guide →How Each Drug Works
Semaglutide
Semaglutide is a GLP-1 receptor agonist — it selectively binds to and activates the GLP-1 receptor, mimicking the effects of the endogenous hormone GLP-1 that is released from intestinal L-cells after eating.
GLP-1 receptor activation produces:
- Glucose-dependent insulin secretion — stimulates first- and second-phase insulin release from pancreatic beta cells only when blood glucose is elevated, reducing the risk of hypoglycemia
- Glucagon suppression — inhibits glucagon secret…
Approved Uses (Indications)
Semaglutide
Ozempic (semaglutide injectable, 0.5–2 mg) is FDA-approved for:
- Type 2 diabetes mellitus — as an adjunct to diet and exercise to improve glycemic control in adults
- Cardiovascular risk reduction — to reduce the risk of major adverse cardiovascular events (MACE: cardiovascular death, non-fatal myocardial infarction, non-fatal stroke) in adults with type 2 diabetes and established cardiovascular disease
Wegovy (semaglutide injectable, 2.4 mg) is FDA-approved for:
- Chronic weight management in adults with initial BMI ≥30 kg/m² (obesity), or ≥27 kg/m² (overweight) with at …
Warfarin
Warfarin sodium tablets are indicated for: Prophylaxis and treatment of venous thrombosis and its extension, pulmonary embolism (PE). Prophylaxis and treatment of thromboembolic complications associated with atrial fibrillation (AF) and/or cardiac valve replacement. Reduction in the risk of death, recurrent myocardial infarction (MI), and thromboembolic events such as stroke or systemic embolization after myocardial infarction. Limitations of Use Warfarin sodium tablets have no direct effect on an established thrombus, nor does it reverse ischemic tissue damage. Once a …
Side Effects
Semaglutide
Serious Side Effects
Common Side Effects
Rare Side Effects
Warfarin
Cost Comparison
Semaglutide
$935–$1,349/month
Semaglutide is available under three brand names with different pricing structures: **Ozempic (injectable, diabetes indication):** - List price: approximately $935–$968 per 4-week supply (all doses) - With Novo Nordisk savings card: as low as $25/month for eligible commercially insured patients - Medicare Part D: covered for type 2 diabetes; prior authorization typically required **Wegovy (injectable, weight management):** - List price: approximately $1,349/month - With Novo Nordisk savings card: as low as $25/month for eligible commercially insured patients - Medicare Part D: covered for weight management (Inflation Reduction Act, 2024) and for cardiovascular risk reduction (SELECT indication); ~$50–$100/month copay typical **Rybelsus (oral tablet):** - List price: approximately $935–$968/month (same as Ozempic) - With Novo Nordisk savings card: as low as $10/month for eligible commercially insured patients - Medicare Part D: covered for type 2 diabetes No FDA-approved generic semaglutide exists as of 2026. Compounded semaglutide is no longer permitted under the shortage exemption following the FDA's declaration that the shortage has been resolved (March 2025 for Ozempic/Wegovy; April 2025 for Rybelsus).
Warfarin
$10–$30/month
Warfarin is available as a generic and is generally very affordable. Using discount cards like GoodRx can often reduce the cost further, even without insurance.
Drug Interaction: Moderate
Semaglutide can potentially increase the effect of warfarin, leading to a higher risk of bleeding. This interaction is generally not considered severe but requires careful monitoring, especially when semaglutide is initiated or its dose is changed.
Mechanism: While a direct pharmacokinetic interaction is not well-established, semaglutide can cause gastrointestinal side effects (e.g., nausea, vomiting, diarrhea) which may alter the absorption of warfarin or affect vitamin K intake, thereby impacting INR levels. Additionally, significant weight loss induced by semaglutide could potentially alter warfarin pharmacokinetics or pharmacodynamics.
Compare prices for Semaglutide and Warfarin
Check real-time pharmacy prices before you fill — free, no account needed.
Protect your muscle mass on GLP-1 medications
GLP-1 medications can cause up to 39% muscle loss alongside fat. Zova's AI-powered protocol — backed by Lancet Diabetes & Endocrinology research — reduces that to just 8.7% through leucine tracking and injection-day adaptive nutrition.
No credit card. No commitment.
Medical Disclaimer
The information on RxGuide is intended for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician, pharmacist, or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.